Evaluatıon Of Extrapulmonary Tuberculosıs Cases Followed Up In The Infectıous Dıseases And Clınıcal Mıcrobıology Clınıc Of A Unıversıty Unıversıty Hospıtal: A 2-Year Retrospectıve Observatıon

Abstract

AİM: We were aimed to retrospectively evaluate the extra pulmonary tuberculosis (tb) cases followed between July 2021-2023 in our trial. METHODS: All patients who were > 18 years old and whose treatment was initiated with a diagnosis of extrapulmonary tb were included in the study. The data were obtained from patient file information. RESULTS: Sixty-seven patients, 40 women and 27 men, were included inthe study. The average age was 52.7 ± 18. Comorbidities were detected in 47 patients (%73,1) and all detected comorbidities are shown in table 1. The symptoms detected in symptomatic patients are shown in table 2.The diagnosis was made histopathologically in 57 of the patients (Table 3). In the remaining patients, treatment was started based on clinical and nonspecific laboratory findings. Microbiological sampling was performed in only 30 of the patients, and it was determined that 7 of these patients had tb culture positivity and 2 had EZN staining positivity.The most common extrapulmonary involvement is lymph node (56.7%), followed by the gastrointestinal system (11.9%), musculoskeletal system (9%), pleura (9%), genitourinary system (4.5), skin (4.5%) and pericardium. (4.5%) and central nervous system (1.5%).Treatment durations and treatment responses of the patients are shown in table 4, and drug side effects are shown in table 5. CONCLUSION: In our study, it was found that TB most commonly affects lymph nodes other than AC. However, it was determined that microbiological sampling was not performed in more than half of the patients and the diagnosis was made mostly by histopathology.

Keywords

• extra pulmonary tuberculosis
• diagnosis
• treatment
• advers effect